Institute events

RSS feed

M&M’s – Muscle Monday Seminar – 13 September – Charlotte A. Peterson (UK)

Novel roles for satellite cells in muscle adaptation and aging Monday September 13th 2021 from 4pm to 5pm Charlotte A. Peterson (Joseph Hamburg Endowed Professor, Director of the Center for Muscle Biology, UK College of Health Science) On prior registration for people outside the Institute of Myology: medecine-umrs974-myologie@sorbonne-universite.fr More information on the presentation and the speaker   … [Read more]

M&M’s – Muscle Monday Seminar – 6 September – Adam J. Engler (USA)

Age-dependent Cardiac Dysfunction as a Mechanical Disease Monday September 6th 2021 from 4pm to 5pm Adam J. Engler (Professor and Vice-Chair of Bioengineering at UC San Diego, Resident scientist at the Sanford Consortium for Regenerative Medicine, Associate Director of the Medical-Scientist Training Program (MSTP)) On prior registration for people outside the Institute of Myology: medecine-umrs974-myologie@sorbonne-universite.fr > … [Read more]

Release of the 86th newsletter from the Institute – July 2021

Prof. Fabrice Chrétien joined the teams of the Institute of Myology on June 15 as Director of the Center for Neuromuscular Exploration and Assessment which is currently composed by a staff of thirty persons. It encompasses three laboratories and a tissue bank: the Neuromuscular Physiology and Evaluation Laboratory, the NMR and Spectroscopy Laboratory, the Morphological Unit and the biological … [Read more]

Appointment of Piera Smeriglio at the head of BOND group

Piera Smeriglio will take over the management of the BOND Group – Biotherapies for motor neuron disorders (ALS & SMA) following the upcoming departure of Maria Grazia Biferi to whom we send our best wishes and whom we warmly thank for the work she has done with her group within the framework of the Myology … [Read more]

DMD: start at I-Motion of trials with pamrevlumab in ambulatory and non-ambulatory patients

I-Motion is recruiting patients with Duchenne muscular dystrophy to participate in two pharmacological trials designed to test an antifibrotic monoclonal antibody, pamrevlumab (or FG-3019), developed by FibroGen. The objective of these phase III trials is to assess the tolerance, safety and efficacy on the upper limbs, respiratory and cardiac functions of pamrevlumab administered by intravenous … [Read more]

Success for AcadeMYO, the first virtual edition of the Myology Summer School

AcadeMYO, the first fully virtual release of the institute’s Myology Summer School, took place July 5-9. This 2021 edition was a great success. In fact, 115 people attended the courses – nearly twice as many students as during the last face-to-face edition in Paris – including 15 free auditors and 6 representatives of the pharmaceutical … [Read more]

Prof. Fabrice Chrétien joins the Institute of Myology to head the Neuromuscular Exploration and Evaluation Centre

With mixed medical and scientific training, Prof. Fabrice Chrétien has more than 20 years of medical experience in anatomopathology and more than 30 years of research experience in neuropathology. Fabrice Chrétien joined the teams of the Institute of Myology on June 15 as Director of the Center for Neuromuscular Exploration and Assessment currently having around thirty … [Read more]

The Institute is recruiting a Postdoctoral fellow (SMA) for the Centre for Research in Myology

The “Biotherapies for motor neuron disorders group” (BOND) is looking for a postdoctoral fellow to lead a research project on the understanding of novel molecular mechanisms involved in the Spinal Muscular Atrophy (SMA) pathogenesis. The project includes in vitro studies on mouse and human cell lines, analysis of human biopsies and in vivo tests on … [Read more]

The Institute is recruiting a Postdoctoral fellow (SLA) for the Centre for Research in Myology

The “Biotherapies for motor neuron disorders group” (BOND) is looking for a postdoctoral fellow to lead a preclinical research project on the evaluation of the therapeutic effects of a gene therapy strategy for the treatment of Amyotrophic Lateral Sclerosis (ALS) caused by mutation of the SOD1 gene. The project includes in vitro studies on human … [Read more]

M&M’s – Muscle Monday Seminar – 5 July – Silvère M van der Maarel (The Netherlands)

Facioscapulohumeral muscular dystrophy: a monogenic disease with marked clinical, genetic and nuclear heterogeneity Monday July 5th 2021 from 12 am to 1 pm Silvère M van der Maarel (Professor of Medical Epigenetics, Chair Department of Human Genetics, Board Member Division 4, Leiden University Medical Center) Hosted by Piera Smeriglio On prior registration for people outside the … [Read more]